BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 14, 2009
View Archived Issues
Novel piperidine derivatives claimed by Astellas Pharma
Read More
Novel anaplastic lymphoma kinase inhibitors claimed by IRM
Read More
Nitric oxide releasing derivatives of paracetamol patented
Read More
Bardoxolone methyl improves renal function in patients with chronic kidney disease
Read More
Novel antibacterial agents claimed by AstraZeneca
Read More
Novel protein kinase inhibitors described by IRM for the treatment of asthma
Read More
Atrial natriuretic peptide prevents contrast-induced nephropathy in patients with renal failure
Read More
Leflunomide acts as an immunosuppressant in kidney and/or pancreas transplant patients
Read More
Pre- and in-hospital initiation of tirofiban show similar benefits in myocardial infarction patients
Read More
Statin dose effect on HDL-cholesterol not uniform across agents
Read More
Dosing of anakinra in experimental myocardial infarction investigated
Read More
BioAlliance to complete NDA for Loramyc with new data
Read More
Donor lymphocyte infusion therapy increases post stem-cell transplantation survival rates
Read More
Results from a phase III study of Nuvigil in jet lag disorder announced by Cephalon
Read More
FDA Advisory Committee reviews Seroquel XR supplemental NDA
Read More
Merck & Co. and Cardiome sign license agreement for vernakalant for atrial fibrillation
Read More
Myriad receives IND approval for new cancer drug, MPC-3100
Read More
Nippon Shinyaku and Lilly enter agreement for new tadalafil indications
Read More
Othera reports interim phase II OT-551 results for dry AMD
Read More
Cell Therapeutics initiates rolling NDA for pixantrone
Read More
Prometheus and Rosetta Genomics enter license and collaboration agreement
Read More
Simponi approved for RA, psoriatic arthritis and ankylosing spondylitis
Read More
Aegis and Phylogica collaborate to deliver intranasal Phylomer peptide drugs
Read More
Celldex Therapeutics enhances immunotherapy platform
Read More
PAION and Ergomed report phase II data for CNS-5161 in neuropathic cancer pain
Read More
Ipsen provides update of FDA's review of its botulinum toxin type A product
Read More
Glenmark's molecule for neuropathic pain, GRC-10693, completes phase I trials
Read More